Technological Leadership IMI’s expertise in tamper-evident technologies for IV syringes and delivery systems positions it as a leader in secure medication administration, offering opportunities to collaborate on cutting-edge safety solutions with healthcare providers and pharmaceutical companies.

Strategic Partnerships Recent collaborations with companies such as Grifols Canada Therapeutics and Kiro Grifols demonstrate IMI’s growing influence and open channels for joint product development, distribution, and integrated solutions tailored to global healthcare markets.

Market Expansion IMI’s move into the home health sector through partnerships with distributors like IMS suggests potential sales opportunities in emerging healthcare settings that prioritize secure, user-friendly drug delivery devices for at-home and alternative site use.

Regulatory Certainty Compliance with ISO 13485 and relevant medical device directives enhances IMI’s credibility, making its product portfolio attractive to clients looking for certified, high-quality safety devices for sensitive medical applications worldwide.

Innovation & Trends IMI’s engagement with RFID technology via DoseID signals a focus on leveraging advanced tracking and authentication solutions, presenting cross-selling prospects for inventory management, drug safety, and anti-counterfeiting technologies in healthcare.